Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: A systematic review

Head and Neck

Volumn 35, Issue 11, 2013, Pages 1662-1668

  Mujica Mota, Mario ^a   Waissbluth, Sofia ^a   Daniel, Sam J ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

cancer; cochlea; head and neck; radiotherapy; sensorineural hearing loss

Indexed keywords

CANCER RADIOTHERAPY; CONFERENCE PAPER; HEAD AND NECK CANCER; HUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CANCER; COCHLEA; HEAD AND NECK; RADIOTHERAPY; SENSORINEURAL HEARING LOSS;

COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886398403     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23201     Document Type: Conference Paper

References (33)

1. Robbins ME, Zhao W,. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 2004; 80: 251-259.
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Schwartz DL, Garden AS,. Radiotherapy for head and neck cancer. Hematol Oncol Clin North Am 2006; 20: 259-285.
4. Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R,. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003; 29: 417-430.
5. van der Putten L, de Bree R, Plukker JT, et al. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck 2006; 28: 902-908.
6. Ondrey FG, Greig JR, Herscher L,. Radiation dose to otologic structures during head and neck cancer radiation therapy. Laryngoscope 2000; 110 (2 Pt 1): 217-221.
7. Grau C, Moller K, Overgaard M, Overgaard J, Elbrond O,. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991; 21: 723-728.
8. Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM,. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007; 67: 469-479.
9. Downs SH, Black N,. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
10. Li JJ, Guo YK, Tang QL, et al. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma. J Laryngol Otol 2010; 124: 32-36.
11. Sumitsawan Y, Chaiyasate S, Chitapanarux I, et al. Late complications of radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 2009; 36: 205-209.
12. Yilmaz YF, Aytas FI, Akdogan O, et al. Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation. Otol Neurotol 2008; 29: 461-463.
13. Low WK, Burgess R, Fong KW, Wang DY,. Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope 2005; 115: 1823-1826.
14. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR,. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2005; 61: 1393-1402.
15. Wang LF, Kuo WR, Ho KY, Lee KW, Lin CS,. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otol Neurotol 2004; 25: 168-173.
16. Leighton SE, Kay R, Leung SF, Woo JK, Van Hasselt CA,. Auditory brainstem responses after radiotherapy for nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 1997; 22: 350-354.
17. Wakisaka H, Yamada H, Motoyoshi K, Ugumori T, Takahashi H, Hyodo M,. Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 2011; 38: 95-100.
18. Chan SH, Ng WT, Kam KL, et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 2009; 73: 1335-1342.
19. Chen WC, Liao CT, Tsai HC, et al. Radiation-induced hearing impairment in patients treated for malignant parotid tumor. Ann Otol Rhinol Laryngol 1999; 108: 1159-1164.
20. Schot LJ, Hilgers FJ, Keus RB, Schouwenburg PF, Dreschler WA,. Late effects of radiotherapy on hearing. Eur Arch Otorhinolaryngol 1992; 249: 305-308.
21. Munro AJ,. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83-91.
22. Vokes EE,. Induction chemotherapy for head and neck cancer: recent data. Oncologist 2010; 15 Suppl 3: 3-7.
23. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V,. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007; 226: 157-167.
24. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
25. Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 1995; 35: 11-15.
26. Raaijmakers E, Engelen AM,. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol 2002; 65: 1-7.
27. Honoré HB, Bentzen SM, Moller K, Grau C,. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 2002; 65: 9-16.
28. Bhide SA, Harrington KJ, Nutting CM,. Otological toxicity after postoperative radiotherapy for parotid tumours. Clin Oncol (R Coll Radiol) 2007; 19: 77-82.
29. Bhandare N, Jackson A, Eisbruch A, et al. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 2010; 76 (3 Suppl): S50-S57.
30. Fleury B, Lapeyre M,. Tolerance of normal tissues to radiation therapy: ear [Article in French] Cancer Radiother 2010; 14: 284-289.
31. Grewal S, Merchant T, Reymond R, McInerney M, Hodge C, Shearer P,. Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group. Pediatrics 2010; 125: e938-e950.
32. Parham K, McKinnon BJ, Eibling D, Gates GA,. Challenges and opportunities in presbycusis. Otolaryngol Head Neck Surg 2011; 144: 491-495.
33. Grau C, Moller K, Overgaard M, Overgaard J, Elbrond O,. Auditory brain stem responses in patients after radiation therapy for nasopharyngeal carcinoma. Cancer 1992; 70: 2396-2401.